Lessons from an Experiential Approach to Patient Community Engagement in Rare Disease.

[1]  S. Grant,et al.  Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy , 2019, Orphanet Journal of Rare Diseases.

[2]  S. Espin,et al.  Group-based storytelling in disease self-management among people with diabetes , 2019, Chronic illness.

[3]  I. J. Lobera,et al.  Storytelling as a Therapeutic Tool for Family Support in Bulimia Nervosa , 2019, Anorexia and Bulimia Nervosa.

[4]  Y. Bombard,et al.  Engaging patients to improve quality of care: a systematic review , 2018, Implementation Science.

[5]  Hanns Lochmüller,et al.  Duchenne muscular dystrophy and caregiver burden: a systematic review , 2018, Developmental medicine and child neurology.

[6]  J. Bridges,et al.  Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy , 2018, Quality of Life Research.

[7]  S. Dy,et al.  Project Transform: engaging patient advocates to share their perspectives on improving research, treatment and policy , 2018, Current medical research and opinion.

[8]  S. Kahn,et al.  Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases , 2018, Orphanet Journal of Rare Diseases.

[9]  D. Menon,et al.  Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review , 2017, Orphanet Journal of Rare Diseases.

[10]  D. Pushparajah.  Making Patient Engagement a Reality , 2017, The Patient - Patient-Centered Outcomes Research.

[11]  A. Fink,et al.  Engaging Patients and Caregivers Managing Rare Diseases to Improve the Methods of Clinical Guideline Development: A Research Protocol , 2017, JMIR research protocols.

[12]  M. Seres,et al.  Defining patient centricity with patients for patients and caregivers: a collaborative endeavour , 2017, BMJ Innovations.

[13]  J. Bridges,et al.  Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  P. Wicks,et al.  Increasing Patient Involvement in Drug Development. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  K. Flanigan,et al.  How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration , 2015, Orphanet Journal of Rare Diseases.

[16]  Marc Boutin,et al.  Partnering With Patients in the Development and Lifecycle of Medicines , 2015, Therapeutic innovation & regulatory science.

[17]  E. Kaltenthaler,et al.  Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders. , 2015, Health technology assessment.

[18]  Laurie Burke,et al.  Patient-Focused Drug Development: A New Direction for Collaboration , 2015, Medical care.

[19]  John F P Bridges,et al.  A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. , 2014, Clinical therapeutics.

[20]  J. Sloan,et al.  Patient engagement in research: a systematic review , 2014, BMC Health Services Research.

[21]  B. Wong,et al.  Health-Related Quality of Life in Children and Adolescents With Duchenne Muscular Dystrophy , 2012, Pediatrics.

[22]  Carsten Schultz,et al.  How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction. , 2012, Health policy.

[23]  T. Greenhalgh,et al.  Storylines of Self-Management: Narratives of People with Diabetes from a Multiethnic Inner City Population , 2011, Journal of health services research & policy.

[24]  Ségolène Aymé,et al.  Empowerment of patients: lessons from the rare diseases community , 2008, The Lancet.

[25]  L. Shulman,et al.  Making Patient-centered Care Come Alive: Achieving Full Integration of the Patient’s Perspective , 2003, The Journal of nursing administration.